WOMEN HEALTH CARE PROFESSIONALS MENU Updates Explore Medicines360’s latest news and resources ALL UPDATES BLOG PRESS RELEASES PUBLICATIONS NEWS PUBLICATIONS 1 NOV 2017 [Journal of Contraception] Bleeding patterns do not differ between obese and non-obese women using a levonorgestrel 52 mg intrauterine system Read More > PUBLICATIONS 5 OCT 2017 [Journal of Contraception] Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use Read More > PUBLICATIONS 6 MAY 2017 [Journal of Obstetrics & Gynecology] Four-year efficacy and safety of the Liletta™ levonorgestrel intrauterine system Read More > PUBLICATIONS 1 NOV 2016 [American Journal of Obstetrics & Gynecology] A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement Read More > PUBLICATIONS 1 OCT 2016 [Journal of Contraception] Levonorgestrel release rates over five years with the Liletta™ 52 mg intrauterine system Read More > PUBLICATIONS 1 MAY 2016 [Journal of Obstetrics & Gynecology] Return of spontaneous menses and fertility after removal of the Liletta™ levonorgestrel intrauterine system Read More > 1 2 NEXT FEATURED UPDATES NEWS 11 MAR 2019 International Women’s Day at Direct Relief International SANTA BARBARA INDEPENDENT – Direct Relief’s Kirchmaier Volunteer Center was standing room only Friday morning, March 8, as more than 150 people gathered in honor of International Women’s Day to celebrate achievements and acknowledge remaining hurdles, including the lack of global access to affordable maternal health care. This year’s theme was “balance for better — […] Read More > PRESS RELEASES 6 SEP 2018 Medicines360, Afaxys Partner to Expand Public Health Access to LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg Strategic alliance will increase engagement with U.S. public health clinics and their patients about hormonal IUDs (long-acting reversible contraceptives, or LARCs) SAN FRANCISCO and CHARLESTON, S.C. – Medicines360 and Afaxys Pharma, LLC, two mission-driven, socially conscious women’s health pharmaceutical companies, today announced their collaboration to promote Medicines360’s intrauterine system (IUS), LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg, which is […] Read More > NEWS 30 MAY 2018 Medicines360 Expands Access To Contraception In Africa FORBES – Medicines360, the non-profit pharmaceutical company behind the hormonal IUD Liletta, is on a mission to increase women’s access to reproductive care around the world. This month, the female-led company announced the launch of Avibela, a hormonal IUD, in Madagascar. Read More > Sign up for news and updates Women Health Care Professionals Our Mission Resources Donate Avibela Project Who We Are Contact Us Jobs Our Team Leadership Board of Directors Founder Products & Pipeline Clinic Locator Updates Blog Press Releases Publications News © 2021 Medicines360. A 501(c)(3) tax-exempt organization. Medicines360® and its design are registered trademarks of Medicines360. All other trademarks are property of their respective owners. Privacy Policy Terms of Use Compliance Community Guidelines Contact Us